Back to search
ATP-Binding Cassette Subfamily C Member 6 Deficiency
Clinical trial pipeline · Data from ClinicalTrials.gov
See which ATP-Binding Cassette Subfamily C Member 6 Deficiency trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which ATP-Binding Cassette Subfamily C Member 6 Deficiency trials you may qualify forThe primary purpose of Study INZ701-104 (the ENERGY study) is to assess the safety and tolerability of INZ-701 in infants with ENPP1 Deficiency or with ABCC6 De…
The purpose of this prospective registry is to characterize the natural history of ectonucleotide pyrophosphatase/phosphodiesterase1(ENPP1) Deficiency and the i…
The purpose of this study (Study INZ701-304 \[ADAPT\]) is to assess the long-term safety of INZ-701 in patients with ENPP1 Deficiency or ABCC6 Deficiency who ha…
The purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics PD) of multiple ascending doses of INZ-701, an ecto…
The purpose of this prospective study is to characterize the natural history of ENPP1 Deficiency and the early-onset form of ABCC6 Deficiency longitudinally. Th…